fluorescein-5-isothiocyanate has been researched along with Cardiomyopathies, Primary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rösen, P; Rösen, R; Rump, AF | 1 |
1 other study(ies) available for fluorescein-5-isothiocyanate and Cardiomyopathies, Primary
| Article | Year |
|---|---|
The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Cardiomyopathies; Dextrans; Diabetes Mellitus, Type 1; Diastole; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glycated Hemoglobin; Heart; Heart Rate; In Vitro Techniques; Myocardial Contraction; Perfusion; Rats; Rats, Inbred BB; Systole; Ventricular Function, Left | 1995 |